BBC Equity TV Agreement 6 Jun 2016.pdfEquity Audio Agreement 2017-18Voice Rates Card.pdfWalk-on Rate Card 2017 .pdfequity audio agreement 2017 18 finalITV Main – Walk-On Agreement Jan 2016 – .pdfTAC Equity Walk-on Agreement 1. January 2018 WELSH.pdfTAC Equity Walk-on Agreement 2018 ENGLISH.pdf Full agreement is available in rates and agreements. Artist Form of Engagement for Films (Only Non-Commercial Applications) effective April 6, 2018 thr April 5, 2019.pdfArtist Form of Engagement for Student Films from April 6, 2018 to April 5, 2019.pdfSpoken Voice Recordings for Non-Educational Broadcast Use.pdf Current pay rates are available here. PLEASE NOTE: Under the UK Theatre/Equity Commercial Theatre COVID-19 Variation Agreement, rates will be frozen for the period 2019/2020 until April 2022, with the exception of touring allowance and livelihoods. PACT Equity Walk-on Agreement.pdfPact Equity Cinema Films Agreement 2016 with revised terms.pdfCFA Digest (Equity Registrations) from April 6, 2018 to April 5, 2019.pdf The television landscape has changed rapidly since the agreement was last updated in 2015 and is barely recognizable. Claire Hood, the organizer of the television, said: ”We are all pleased to have negotiated a deal that reflects the ever-changing sphere of what is traditionally called television content, but now encapsulates platforms such as Subscription Video on Demand. The new agreement will ensure that UK television programmes and actors benefit from a global platform and a happy remuneration. We have worked tirelessly to negotiate an agreement that reflects the true value of our contributions to the industry, but is always up to date to reflect an ever-changing industry. Changes to the agreement with new terms of sale will come into effect on April 8, 2019.
The updated agreement with all the changes is now available. If you have any questions about this, please contact us. PLEASE NOTE: UK Theatre and Equity has agreed to revised provisions for the cancellation of performances until 6 April 2021 under COVID-19.